NCT01611168 REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes Status COMPLETED Phase NA
NCT01610518 The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and Form Status COMPLETED Phase NA
NCT01609582 Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease Status TERMINATED Phase PHASE3
NCT01607294 A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01606007 Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01600924 Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01597531 Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding Status TERMINATED Phase PHASE4
NCT01595594 Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics Status COMPLETED Phase PHASE3
NCT01593215 Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant Status COMPLETED Phase PHASE2
NCT01593137 A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes Status WITHDRAWN Phase PHASE4
NCT01586442 Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01580813 Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes Status COMPLETED Phase NA
NCT01580475 Training, Detraining, Retraining and Glycemic Control in Patients With Type 2 Diabetes Status COMPLETED Phase NA
NCT01579981 The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects Status COMPLETED Phase NA
NCT01576328 Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes Status COMPLETED Phase PHASE1/PHASE2